Organon (OGN) Reports Earnings Tomorrow: What To Expect

Core Insights - Organon is set to announce its earnings results, with analysts expecting flat revenue year on year at $1.57 billion, a slowdown from the previous year's 4.1% increase [2] - Last quarter, Organon reported revenues of $1.59 billion, exceeding analysts' expectations by 2.8% and achieving a strong performance in terms of both revenue and EPS estimates [1][3] Revenue Expectations - Analysts have generally maintained their revenue estimates for Organon over the past 30 days, indicating a stable outlook heading into earnings [3] - The company has missed Wall Street's revenue estimates twice in the last two years, raising concerns about its performance consistency [3] Peer Performance - In the branded pharmaceuticals segment, peers like Eli Lilly and Collegium Pharmaceutical reported significant year-on-year revenue growth of 53.9% and 31.4%, respectively, both exceeding analysts' expectations [4] - Positive sentiment in the branded pharmaceuticals sector is reflected in an average share price increase of 3.9% over the last month, contrasting with Organon's decline of 29.4% during the same period [5] Analyst Sentiment - The average analyst price target for Organon is $10.83, while its current share price stands at $6.78, indicating potential upside if the company can meet or exceed expectations [5]